Black Rock Inc. Rocket Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,192,627 shares of RCKT stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,192,627
Previous 5,929,910
4.43%
Holding current value
$19.9 Million
Previous $160 Million
16.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCKT
# of Institutions
257Shares Held
107MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$56.8 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$40.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$21.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$16.7 Million0.68% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.5 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $243M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...